Prices are updated after-hours
Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : America    symbols : ONCY    save search
Oncolytics Biotech® Provides Enrollment Update on Multi-Indication Phase 1/2 Gastrointestinal Cancer Trial at the 2022 American Society of Clinical Oncology Gastrointestinal Cancers Symposium
Published: 2022-01-20 (Crawled : 14:00) - biospace.com/
ONCY | $1.045 -3.24% -3.35% 180K twitter stocktwits trandingview |
Health Technology
 | | O: 4.37% H: 6.81% C: 3.14%
biotech america symposium gastrointestinal trial phase 1 test cancer iot enroll
Gainers vs Losers
71% 29%

Top 10 Gainers
AGBA | News | $1.27 217.5% 120M twitter stocktwits trandingview |
Finance
EGOX | $0.0503 39.72% 320M twitter stocktwits trandingview |

RWOD | $10.52 31.56% 5.9M twitter stocktwits trandingview |
n/a
ZCMD | $1.905 31.38% 30M twitter stocktwits trandingview |
Commercial Services
MRDB 4 | $0.536 27.65% 2M twitter stocktwits trandingview |
n/a
BSFC | $0.0822 27.64% 75M twitter stocktwits trandingview |
Manufacturing
TPET | $0.4121 25.68% 45M twitter stocktwits trandingview |
n/a
NVFY | $2.65 25.59% 33M twitter stocktwits trandingview |
Consumer Durables
INDO | $5.1 25.0% 15M twitter stocktwits trandingview |
Energy Minerals
CHRO | $1.53 24.9% 100K twitter stocktwits trandingview |
n/a
Your saved searches
Save your searches and get alerts when important news are released.